UBS Group AG VTVT — VTV THERAPEUTICS INC

Ownership history in UBS Group AG  ·  34 quarters on record

AI Ownership Summary

UBS Group AG reported VTV THERAPEUTICS INC (VTVT) in 34 quarterly 13F filings from 2024 Q2 through 2026 Q3. The latest visible filing shows VTVT at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this VTVT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was UBS Group AG's position in VTV THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

VTVT was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2026 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How UBS Group AG held VTVT — position size vs. price
% of Fund (quarterly)    VTVT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 ADDED — — — 11,319 +9,144 +420.4% 0.00% $349K 2026-11-10 $21.00
2026 Q2 REDUCED 61.4% -18.9% ✅ 2,175 -3,461 -61.4% 0.00% $82K 2026-08-13 $30.85
2026 Q1 ADDED — — — 5,636 +3,968 +237.9% 0.00% $224K 2026-05-15 (Est.) $35.69
2025 Q4 REDUCED 43.8% -0.8% ✅ 1,668 -1,302 -43.8% 0.00% $67K 2026-01-29 $34.15
2025 Q3 ADDED — — — 2,970 +123 +4.3% 0.00% $69K 2025-11-13 $31.27
2025 Q2 REDUCED 29.5% +52.9% ❌ 2,847 -1,193 -29.5% 0.00% $43K 2025-08-14 $15.30
2025 Q1 REDUCED 46.2% -13.4% ✅ 4,040 -3,472 -46.2% 0.00% $70K 2025-05-13 $20.80
2024 Q4 ADDED — — — 7,512 +6,646 +767.4% 0.00% $104K 2025-02-14 $21.70
2024 Q3 REDUCED 79.3% +3.0% ❌ 866 -3,314 -79.3% 0.00% $12K 2024-11-14 $15.64
2024 Q2 ADDED — — — 4,180 +2,723 +186.9% 0.00% $74K 2024-08-14 $13.31
24 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About UBS Group AG and VTVT

These are the practical questions this page is built to answer before you even open the full history table.

How long has UBS Group AG reported owning VTVT?

UBS Group AG reported VTVT across 10 quarterly 13F filings, from 2024 Q2 through 2026 Q3.

What was the largest reported VTVT position in UBS Group AG's portfolio?

The largest reported portfolio weight for VTVT was 0.00% in 2026 Q3.

What is the latest reported VTVT position on this page?

The most recent filing on this page is 2026 Q3, when UBS Group AG reported 11,319 shares, equal to 0.00% of portfolio, with an estimated market value of $349K.

What does the chart on this VTVT ownership page compare?

The chart compares UBS Group AG's quarterly VTVT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did UBS Group AG time their VTVT position?

Based on 13F filing dates vs. subsequent VTVT price moves, UBS Group AG correctly timed 16 out of 30 reported position changes (53%). The annualised alpha on VTVT relative to SPY over the holding period was -35.9%.

← Back to UBS Group AG Holdings